Children’s Behavioral Health & Residential Treatment

Applying for Children’s Residential Care Facility Services

CBHS contracts with Acentra to manage Children’s Residential Care Facility Services (CRCF). Children’s Residential Care Facility Services for children follows the MaineCare Section 97 eligibility criteria. Acentra processes all applications and completes Prior Authorizations for Children’s Residential Care Facility Services, and they are your contact related to approval for admissions to Children’s Residential Care Facility.

10-148 C.M.R. ch. 31; Quality Rating and Improvement System: Rising Stars for ME

This rule outlines how the Maine Department of Health and Human Services (the Department) pays a differential rate for child care services that meets or that makes substantial progress toward meeting nationally recognized quality standards, as required by 22 M.R.S.A § 3737. The emergency rulemaking allows the Department to immediately start paying a higher quality differential to such early care and education programs, addressing the lack of access to high-quality early care and education programs in Maine, which presents an ongoing threat to Maine’s general welfare.

Delayed July 1, 2025, Cost-of-Living Adjustment (COLA) for Section 97, Appendix C, Residential Care Facilities (RCFs)

The Department is temporarily delaying implementation of the previously announced 1.0% COLA rates for RCF direct care. The Department requires additional time to make these updates, and we anticipate implementation of new rates on October 1, 2025.

Billing Guidance for Dates of Service July 1, 2025, through September 30, 2025

Discontinuation of Coverage: Xifaxan (Rifaximin)*

Effective October 1, 2025, the manufacturer of Xifaxan (Rifaximin) will no longer participate in the Medicaid Drug Rebate Program which means it will not be covered by MaineCare. Please read below for alternative options.

Patient Assistance Program for Free Medication

Bausch Health Companies, Inc. offers a patient assistance program aimed at supplying free medication, including Xifaxan, to eligible patients who do not have coverage under their Medicaid pharmacy benefit.  

Subscribe to